About us
Our group develop advanced biofabrication technologies such as
organ-on-chip models and 3D bioprinting for disease modeling, drug screening and injury repair, we use these novel tools to study fibrosis-related diseases
such as the cause and therapy of idiopathic pulmonary fibrosis and the
effect of fibrotic tumor microenvironment on cancer immunotherapy.